ScreenerHero

MGRX Mangoceuticals, Inc.

NAS · US · Healthcare · Health Information Services · mangoceuticals.com
0.4437USD-1.40%Mkt Cap: 9.57M $P/E: —

Mangoceuticals, Inc. engages in the development, marketing, and sale of various men's wellness products and services through a telemedicine platform in the United States. The company offers erectile dysfunction products …

Industry Peers

Health Information Services
Screen all
VEEV
Veeva Systems Inc.
$45.74BUSDP/E 46.3
TEM
Tempus AI, Inc.
$12.69BUSD
BTSG
BrightSpring Health Services, Inc.
$12.62BUSDP/E 56.5
HNGE
Hinge Health, Inc.
$7.90BUSDP/E 32.3
HQY
HealthEquity, Inc.
$7.60BUSDP/E 33.2
WAY
Waystar Holding Corp.
$4.94BUSDP/E 36.8
DOCS
Doximity, Inc.
$4.94BUSDP/E 32.6
HTFL
Heartflow, Inc.
$4.29BUSD
PRVA
Privia Health Group, Inc.
$2.59BUSDP/E 96.7
SDGR
Schrödinger, Inc.
$2.04BUSD
OMCL
Omnicell, Inc.
$1.61BUSDP/E 41.9
CERT
Certara, Inc.
$1.37BUSD
OMDA
Omada Health, Inc.
$1.28BUSDP/E 87.0
GDRX
GoodRx Holdings, Inc.
$1.11BUSDP/E 65.0
TDOC
Teladoc Health, Inc.
$1.01BUSD
HSTM
HealthStream, Inc.
$982.13MUSDP/E 44.6
PHR
Phreesia, Inc.
$651.74MUSDP/E 61.8
SOPH
SOPHiA GENETICS SA
$608.66MUSD
WEAV
Weave Communications, Inc.
$592.92MUSD
RAY-B
RaySearch Laboratories AB (publ)
$521.70MUSDP/E 29.4

Key Statistics

Company
Market Cap9.57M USD
Enterprise Value9.75M USD
Revenue (TTM)315.23K USD
Gross Profit250.39K USD
Net Income (TTM)-20.64M USD
Revenue/Share0.02 USD
Last Price0.4437 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees3
CountryUS
SectorHealthcare
IndustryHealth Information Services
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-0.81
EV/Revenue30.94
P/S30.79
P/B0.65
EPS (TTM)-1.11
EPS (Forward)—
52W Range
0.162011% of range2.750
52W High2.750 USD
52W Low0.1620 USD
Profitability
Gross Margin54.91%
Oper. Margin-1502.45%
EBITDA Margin0.00%
Profit Margin-4526.76%
ROE-135.80%
ROA-128.30%
Growth
Revenue Growth-59.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-5.85M USD
CapEx (TTM)—
FCF Margin402.54%
FCF Yield13.26%
Net Debt50.52K USD
Net Debt/EBITDA-0.00
Balance Sheet
Debt/Equity0.02
Current Ratio0.18
Quick Ratio0.16
Book Value/Sh0.69 USD
Cash/Share0.01 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split1:15
Split DateOct 16, 2024
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.21.57M
Float17.83M
Insiders7.99%
Institutions5.62%
Short Interest
Short Ratio0.9d
Short % Float2.63%
Short % Out.2.42%
Shares Short521.42K
Short (prev mo.)1.81M
Technical
SMA 500.4499 (-1.4%)
SMA 2000.4559 (-2.7%)
Beta1.98
S&P 52W Chg16.45%
Avg Vol (30d)644.21K
Avg Vol (10d)745.16K
Technical Indicators
RSI (14)50.6
MACD0.0008
MACD Signal-0.0011
MACD Hist.+0.0019
BB Upper0.4887 USD
BB Middle0.4334 USD
BB Lower0.3781 USD
BB Width25.52%
ATR (14)0.0564 USD
Vol Ratio (20d)0.98x